EN2502: Comprehensive Hematology and Oncology Review Course

Instructions

Friday, November 1, 2024, 12:00 AM - Sunday, November 30, 2025, 11:59 PM

AMA PRA Category 1 Credits™ (35.75 hours), Non-Physician (35.75 hours)

Overview
Join our renowned experts from Fred Hutchinson Cancer Center and the University of Washington for the 15th Annual Comprehensive Hematology and Oncology Review Course. This program includes 54 talks covering the breadth of key clinical updates across Hematology and Oncology sub-specialties along with updates on supportive care and associated specialties.

The lectures review data that inform current guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and malignant and benign hematologic disorders. After completing the course, learners will have a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors and hematologic disorders.

METHOD OF PARTICIPATION
To complete this training, access to the internet is required. You will need to attest to your participation and complete an evaluation and competency measurement at the conclusion of your participation. This must be done before the accreditation period concludes on November 30, 2025.

DISCLOSURE SUMMARY

QUESTION & ANSWER SUPPLEMENT

SYLLABUS

 

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited activity, including faculty, planners, reviewers or others in control of content are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the start of the activity.

No faculty are available for this activity at this time.